Clarisse is a Senior Manager at Novartis Pharma in Switzerland. Her most recent assignment is the first Blockchain Business Analyst role created at Novartis. She helps business functions navigate blockchain and evaluate the use of it within their own digital transformation journey.
During the last 12 years of her career in Pharma finance and procurement functions, Clarisse has successfully led projects and teams through multiple waves of organizational and technology transformation.
A firm believer in self-sovereign identity and the importance of enabling health data ownership to patients. Clarisse possesses a personal passion and interest for Blockchain and has shifted her career and learning focus into the area to support the acceleration of awareness, buy-in and development of the enterprise blockchain world.
Clarisse is the appointed Culture and Adoption Program Manager for the PharmaLedger Healthcare consortium, an EU/EFPIA co-funded project facilitated by the Innovative Medicines Initiative and composed by 12 global pharma and 17 public/private companies.